NCT00647946View on ClinicalTrials.gov

Study to Evaluate Changes in Limb Fat When Switching From a Thymidine Analogue

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

October 31, 2004

Study Completion Date

February 28, 2006

Conditions
Lipodystrophy
Interventions
DRUG

tenofovir DF

tenofovir DF 300mg once daily along with the other antiviral drugs

DRUG

abacavir 300mg twice daily

abacavir 300mg twice daily along with the other antiviral drugs

Trial Locations (1)

CB1 6GT

Gilead Sciences, Abingdon

Sponsors

Lead Sponsor

Gilead Sciences
All Listed Sponsors
lead

Gilead Sciences

INDUSTRY

NCT00647946 - Study to Evaluate Changes in Limb Fat When Switching From a Thymidine Analogue | Biotech Hunter | Biotech Hunter